(Q44877341)

7 December 2017

Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa (English)

1 reference

7 December 2017

1 reference

ChEBI release 2020-05-28

ChEBI ID

28864

Pseudomonas aeruginosa

1 reference

3

1 reference

7 December 2017

Misagh Alipour

1

1 reference

PubMed ID

19465435

7 December 2017

Zacharias E Suntres

series ordinal

2

1 reference

PubMed ID

19465435

7 December 2017

language of work or name

English

0 references

publication date

22 May 2009

1 reference

Journal of Antimicrobial Chemotherapy

7 December 2017

1 reference

7 December 2017

64

1 reference

7 December 2017

2

1 reference

7 December 2017

317-325

1 reference

How can we prevent multisystem complications of cystic fibrosis?

7 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Multidrug-resistant organisms in cystic fibrosis: management and infection-control issues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

The Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)homoserine lactone contributes to virulence and induces inflammation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Mucus structure and properties in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Structural alterations of gene complexes by cystic fibrosis sputum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Mucin-Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Should aminoglycoside antibiotics be abandoned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Aminoglycoside nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Dornase alfa in early cystic fibrosis lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Effects of recombinant human DNase and hypertonic saline on airway inflammation in children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Liposomes for drug delivery to the lungs by nebulization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Macromolecular mechanisms of sputum inhibition of tobramycin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Interactions between human neutrophils and mucin-coated surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Elastic contributions dominate the viscoelastic properties of sputum from cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Cystic fibrosis sputum: a barrier to the transport of nanospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

Addition of a bacterial alginate lyase to purulent CF sputum in vitro can result in the disruption of alginate and modification of sputum viscoelasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP165

21 January 2018

Identifiers

DOI

10.1093/JAC/DKP165

1 reference

7 December 2017

1 reference

PubMed ID

19465435